Before the discovery of insulin, diabetes was considered a mysterious and often fatal disease. Characterized by symptoms such as excessive thirst, frequent urination, and weight loss, diabetes primarily affected young adults and children, leading to what was known as “wasting away.” Several ancient civilizations documented these symptoms, but it wasn’t until the 19th century that the scientific community began to understand the role of the pancreas in diabetes.
The Role of Animal Experimentation in Early Discoveries

Animal experimentation has long been a critical component in medical discoveries, and the path to understanding diabetes was no exception. The pivotal role of the pancreas in blood sugar regulation was first hinted at in the late 19th century. In 1889, German researchers Oskar Minkowski and Joseph von Mering made a groundbreaking discovery when they removed the pancreas from dogs. The animals developed symptoms analogous to human diabetes, such as increased blood sugar levels and urination, establishing a direct connection between the pancreas and diabetes.
Insights from Pancreatic Extracts

Scientists continued their exploration of the pancreas for several decades, honing in on the “islets of Langerhans,” a group of cells within the pancreas named after their discoverer, Paul Langerhans. Researchers surmised that these cells might secrete a substance crucial for sugar metabolism. In the early 20th century, various scientists attempted to treat diabetic animals with pancreatic extracts, but the results were inconsistent, in part due to impurities in the extracts that led to toxicity.
Breakthrough: The Discovery of Insulin

In 1921, a significant breakthrough came thanks to the collaborative efforts of Canadian researchers Frederick Banting and Charles Best. They believed that, to prevent digestive enzymes from degrading the hormone responsible for lowering blood sugar, it was essential to obtain extracts from the pancreas after the enzymes were inactive. Using a dog model, they successfully isolated the hormone and dramatically reduced blood sugar levels in diabetic dogs. These experiments provided the first reliable pancreatic extracts, which were later named ‘insulin.’
Refining Insulin for Human Use

The initial success set the stage for mass production of insulin. James Collip, a biochemist, joined Banting and Best in their research and played a crucial role in refining the extracts to remove impurities, making insulin safe for human use. In 1922, Leonard Thompson, a 14-year-old boy with diabetes, became the first human to receive insulin injections. His condition improved almost immediately, marking a historic milestone in diabetes treatment.
Ethical Considerations in Animal Research

The development of insulin as a treatment for diabetes illustrates the vital role of animal experimentation in medical advancements. However, it also highlights ethical considerations surrounding the use of animals in research. Balancing scientific progress with humane treatment of animals remains a crucial issue in the scientific community, emphasizing the necessity for regulations and alternative methods where possible.
The Impact of Insulin Discovery

The discovery of insulin transformed diabetes from a fatal disease to a manageable chronic condition. It saved countless lives and opened avenues for further research into diabetes, including the development of synthetic insulins and advanced delivery systems like insulin pumps and pens. This landmark achievement underscored the potential of animal research to bring about profound medical breakthroughs.
Conclusion: A Legacy of Discovery

The development of insulin showcases the intertwined legacy of scientific curiosity and animal research. While this journey poses ethical questions, it serves as a testament to the progress that can be achieved through careful and considerate scientific inquiry. Understanding the history of insulin not only honors past achievements but also inspires continued advancements in medical science, always with an eye toward ethical innovation.